PD-1, which is expressed on activated T-cells, such as cytotoxic T lymphocytes (CTLs), interacts with its ligands PD-L1 and PD-L2, which are commonly expressed by tumor cells, leading to enhanced inhibitory signaling of T-cell receptor in CTLs29,30. The gene discussed is PDCD1LG2; the disease is neoplasm.